Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
UCSF | Residency/Fellowship | Clinical Pathology / Hematopathology | 2011 |
University of Michigan | PhD | Immunology & Microbiology | 2007 |
University of Michigan | MD | Medicine | 2007 |
University of Texas | BS | Molecular Biology | 1999 |
Awards & Honors
Award | Conferred By | Date |
---|---|---|
Most Highly Cited Researchers over past decade, top 1% | Clarivate | 2022 |
UCSF Medical School Foundations Curriculum Teaching Award | UCSF | 2021 |
American Association of Immunology, Travel Award | AAI | 2019 |
Nina Ireland Program for Lung Health Award | UCSF | 2019 |
AAI Young Investigator Travel Award | UCSF | 2017 |
ICIS Milstein Young Investigator Award | UCSF | 2017 |
New Frontiers Research Awardee Program for Breakthrough Biomedical Research | UCSF | 2017 |
Larry L. Hillblom Foundation Young Investigator Award | UCSF | 2016/2019 |
Mentored Clinical Scientist Research Career Development Award (K08) | UCSF | 2014 |
Molecular Medicine Research Fellowship | UCSF | 2009/2012 |
MD graduate with research distinction | U. of Michigan | 2007 |
Alpha Omega Alpha Medical Honors Society | U of Michigan | 2006 |
Ward J. MacNeal Distinguished Dissertation | U. of Michigan | 2006 |
Frederick G. Novy Fellowship | U. of Michigan | 2004/2005 |
Dean's Honored Graduate in Molecular Biology | U. of Texas | 1999 |
National Merit Finalist Scholarship | U. of Texas | 1995/1999 |
Collaboration Interests
Our research group is fundamentally collaborative, working to understand tissue immunity across multiple organs and disease states. As our grants and publications suggest, we enjoy pushing the scientific boundaries of immunology and its intersections with neuroscience, metabolic diseases, lung biology, and barrier health.
I am interested in:
- academic collaboration
- companies and entrepreneurs
- physician scientist
- policy change
- press
Grants and Funding
- Manipulation of macrophage polarization by a fungal meningitis pathogen | NIH | 2022-06-23 - 2027-05-31 | Role: Principal Investigator
- Meningeal type 2 immunity in cortical synapse remodeling during brain development and injury | NIH | 2022-02-15 - 2026-12-31 | Role: Principal Investigator
- Localization and function of tissue type 2 lymphocytes during mixed inflammation | NIH | 2022-01-11 - 2026-12-31 | Role: Principal Investigator
- Role of Myeloid And CD4+ T Immune Cells in Post-Traumatic Plasticity | NIH | 2021-12-01 - 2026-11-30 | Role: Co-Investigator
- The IL-33/ILC2 axis in parturition | NIH | 2020-01-15 - 2024-12-31 | Role: Co-Investigator
- Defining group 2 innate lymphoid cell lung niches | NIH | 2019-09-01 - 2023-08-31 | Role: Principal Investigator
- Activation, Phenotype and Function of CD4 T Cells in Schistosoma-Pulmonary Hypertension | NIH | 2016-12-15 - 2021-11-30 | Role: Co-Investigator
- Defining group 2 innate lymphoid cell lung niches | NIH | 2018-09-15 - 2019-08-31 | Role: Principal Investigator
- Adipose Tissue type 2 immunity in metabolic health and disease | Larry L. Hillblom Foundation Startup Grant | 2016-08-02 - 2019-07-21 | Role: Principal Investigator
- Regulation and function of allergic immune cells in visceral adipose tissue | NIH | 2014-05-01 - 2019-02-28 | Role: Principal Investigator
- Regulation of lung type 2 immunity in tobacco-related allergic asthma | California TRDRP, New Investigator Award | 2018-07-01 - | Role: PI
- Ghosts in the machine: Lymphocytes in the developing brain | UCSF Quantitative Biosciences Institute Bold and Basic Research Grant | 2017-07-01 - 2018-06-30 | Role: Faculty Mentor
- Exploring innate lymphocytes at the brain-immune interface | Program for Breakthrough Biomedical Research: New Frontier Research | 2017-06-15 - 2018-06-14 | Role: Co-Principal Investigator
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 57
- Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation.| | PubMed
- A worm of one's own: how helminths modulate host adipose tissue function and metabolism.| | PubMed
- Activated type 2 innate lymphoid cells regulate beige fat biogenesis.| | PubMed
- Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy.| | PubMed
- Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells.| | PubMed
- Peripheral T-Cell Lymphoma, Not Otherwise Specified Presenting as Erythroderma| | UCSF Research Profile
- Type 2 innate lymphoid cells control eosinophil homeostasis.| | PubMed
- Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages.| | PubMed
- Two septic transfusion reactions presenting as transfusion-related acute lung injury from a split plateletpheresis unit.| | PubMed
- Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis.| | PubMed